In highly malignant glioblastoma, YTHDF2 disrupts cholesterol metabolism by recognizing m6A modifications on the key cholesterol metabolism factor LXRα and facilitating its degradation, significantly promoting tumor cell proliferation [77]. The gene discussed is YTHDF2; the disease is neoplasm.